Sign in
Taking peopleNo phase

Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study

Key facts

Who runs it
Yuzuncu Yil University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
80 people, planned
Started
15 Apr 2025
Planned end
1 Feb 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Dexmedetomidine
  • Propofol
Record updated
27 August 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients scheduled for rhinoplasty
  • Between 18-65 years
  • ASA I-II group

Who cannot take part

  • Those with renal,hepatic, cardiac and respiratory diseases
  • Those with a known allergy to the medication to be used
  • Those who are outside the age range of 18-65
  • Those who are ASA III and above
  • Those who underwent urinary catheterization

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To compare of prevention of emergence agitation in rhinoplasty with subanesthetic propofol and single dose dexmedetomidine

The 2 groups in the trial

  • Dexmedetomidine (Group-D)Existing treatment, for comparison

    Group-D: Dexmedetomidine group (n:40). In rhinoplasty, 10 minute infusion of 0,5 mcg/kg dexmedetomidine will be administered after nasal packing.

    Treatment: Dexmedetomidine

  • Propofol (Group-P)Treatment being tested

    Group-P: Propofol group (n:40). In rhinoplasty, 0,5 mg/kg propofol IV bolus will be administered after nasal packing.

    Treatment: Propofol

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Van Yuzuncu Yil University Faculty of Medicine Ethics Committee
Fit questions
Built from NCT07144007, who can take part
Record updated
27 August 2025